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Aim
Vertical HIV transmission is a public health problem in
Burkina Faso. This study on the prevention of mother to
child HIV-1 transmission had the objectives to: i) deter-
mine the residual rate of vertical HIV transmission by PCR
ii) Detect of HIV antiretroviral drugs resistance among
mother-infant pairs and iii) Identify sub-types and Circulat-
ing recombinant form (CRF) in Burkina Faso.
Materials and methods
In this study, 3,215 samples of pregnant women were
analyzed using rapid tests “Determine HIV1/2”. Vertical
transmission was estimated by PCR in newborns from
those who were HIV positive. HIV-1 Resistance to ARVs,
subtypes and CRFs were determined through ViroSeq kit
using the ABI PRISM 3130 sequencer.
Results
In this study, 12.26% (394/3215) of the pregnant women
were diagnosed HIV-positive, 0.52% (2/388) overall resi-
dual rate of transmission was identified with rates of
1.75% (2/114) among mothers under prophylaxis and
0.00% (0/274) for those under HAART. Genetic mutations
have also been isolated that induce resistance to ARVs like
M184V, Y115F, K103N, Y181C, v179E, G190A, etc. And
there were subtypes and circulating recombinant forms
(CRF) of HIV-1 such as: CRF06_CPX (58.8%), CRF02_AG
(35.3%) and subtype G (5.9%).
Conclusion
Antiretroviral drugs reduce the residual rate of HIV verti-
cal transmission. However, they cause mutations that
induce resistance of HIV to antiretroviral therapy. Resis-
tance to ARV therefore requires a permanent dialogue
between clinicians, prescribers, pharmacists, and the
creation of a network of monitoring and surveillance of
drug resistance in Burkina Faso.
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